{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:04:33Z","timestamp":1792026273232,"version":"4.4.0"},"reference-count":61,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Moffitt Cancer Center Insitutional Innovation","award":["02-40000-26-23"],"award-info":[{"award-number":["02-40000-26-23"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Myosteatosis\u2014fat infiltration within skeletal muscle\u2014is emerging as a critical yet underappreciated determinant of cancer outcomes. Although historically overshadowed by sarcopenia and cachexia, myosteatosis is now recognized as a distinct and early muscle phenotype that carries significant prognostic implications across multiple tumor types. Despite its relevance, foundational gaps remain in our understanding of its mechanisms, clinical significance, and therapeutic potential. The goal of this manuscript is to review the current literature to identify the unique characteristics, prevalence, biological and other etiological mechanisms of myosteatosis and its role as an early biomarker in cancer treatment, recurrence, and prognosis. Methods: A review of the evidence from epidemiological, laboratory and other observational studies with regard to the definition of the biomarker, its biological mechanism, its prevalence in cancer patient populations and the gaps in the research was conducted. Results: Retrospective studies utilizing CT imaging reveal that myosteatosis is highly prevalent in cancer populations and independently associated with mortality, treatment toxicity, postoperative complications, functional decline, and survivorship outcomes. Unlike sarcopenia, which primarily reflects loss of muscle mass, myosteatosis reflects impaired muscle quality, metabolic dysfunction, and lipid derangements. Importantly, it appears early in the trajectory of muscle deterioration\u2014well before irreversible cachexia develops\u2014making it a strategic point for intervention. Conclusions: Despite strong associations with clinical outcomes, the biological underpinnings, clinical applications, and modifiability of myosteatosis remain poorly defined. A coordinated research agenda focused on mechanistic discovery, biomarker standardization, and targeted interventions is essential to improving survival, treatment tolerance, and quality of life for patients across the cancer continuum.<\/jats:p>","DOI":"10.3390\/cancers18060974","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:35:08Z","timestamp":1773819308000},"page":"974","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Myosteatosis: A Distinct, Early and Targetable Novel Biomarker of Cancer Prognosis"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6121-2627","authenticated-orcid":false,"given":"Nagi B.","family":"Kumar","sequence":"first","affiliation":[{"name":"Cancer Epidemiology Program, Moffitt Cancer Center and Research Institute, MRC-CAN CONT, 13131 Magnolia Drive, Tampa, FL 33612, USA"},{"name":"Genitourinary Oncology Program, Moffitt Cancer Center and Research Institute, MRC-CAN CONT, 13131 Magnolia Drive, Tampa, FL 33612, USA"},{"name":"Breast Oncology Program, Moffitt Cancer Center and Research Institute, MRC-CAN CONT, 13131 Magnolia Drive, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"ref_1","unstructured":"American Cancer Society (2025). Cancer Facts & Figures 2025, American Cancer Society."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(25)01570-3","article-title":"Global cancer burden: Progress, projections, and challenges","volume":"406","author":"Luo","year":"2025","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11864-010-0127-z","article-title":"Cancer cachexia: Traditional therapies and novel molecular mechanism-based approaches to treatment","volume":"11","author":"Kumar","year":"2010","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bossi, P., Delrio, P., Mascheroni, A., and Zanetti, M. (2021). The Spectrum of Malnutrition\/Cachexia\/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review. Nutrients, 13.","DOI":"10.3390\/nu13061980"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"990S","DOI":"10.1093\/jn\/127.5.990S","article-title":"Sarcopenia: Origins and clinical relevance","volume":"127","author":"Rosenberg","year":"1997","journal-title":"J. Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"19551","DOI":"10.1038\/s41598-020-75250-y","article-title":"Prevalence and risk factors of primary sarcopenia in community-dwelling outpatient elderly: A cross-sectional study","volume":"10","author":"Therakomen","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.clnu.2024.10.017","article-title":"The prognostic value of myosteatosis in pancreatic cancer: A systematic review and meta-analysis","volume":"43","author":"Chen","year":"2024","journal-title":"Clin. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1200\/JCO.21.00102","article-title":"Sarcopenia in the older adult with cancer","volume":"39","author":"Williams","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/annonc\/mdx271","article-title":"Forcing the vicious circle: Sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy","volume":"28","author":"Bozzetti","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/jcsm.13339","article-title":"Apples to apples? Discordant definitions still hinder evidence-based treatments for sarcopenia","volume":"14","author":"Coletta","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"101883","DOI":"10.1016\/j.arr.2023.101883","article-title":"An elusive consensus definition of sarcopenia impedes research and clinical treatment: A narrative review","volume":"86","author":"Coletta","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/jcsm.13183","article-title":"Albumin-myosteatosis gauge as a novel prognostic risk factor in patients with non-metastatic colorectal cancer","volume":"14","author":"Kim","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.ejso.2020.03.206","article-title":"The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients\u2014A retrospective register study","volume":"46","author":"Aro","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/jcsm.12575","article-title":"Prognostic impact of myosteatosis in patients with colorectal cancer: A systematic review and meta-analysis","volume":"11","author":"Lee","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kamiliou, A., Lekakis, V., Xynos, G., and Cholongitas, E. (2024). Prevalence of and Impact on the Outcome of Myosteatosis in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancers, 16.","DOI":"10.3390\/cancers16050952"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3348\/kjr.2022.0277","article-title":"Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma","volume":"23","author":"Kim","year":"2022","journal-title":"Korean J. Radiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.clnu.2023.10.006","article-title":"Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer","volume":"42","author":"Zhang","year":"2023","journal-title":"Clin. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Correa-de-Araujo, R., Addison, O., Miljkovic, I., Goodpaster, B.H., Bergman, B.C., Clark, R.V., Elena, J.W., Esser, K.A., Ferrucci, L., and Harris-Love, M.O. (2020). Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00963"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jcsm.12646","article-title":"Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models","volume":"12","author":"Nachit","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3748\/wjg.v30.i8.863","article-title":"Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor","volume":"30","author":"Deng","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nutres.2021.08.003","article-title":"Myosteatosis reduces overall survival in patients with digestive system malignancies: A meta-analysis with trial sequential analysis","volume":"94","author":"Wang","year":"2021","journal-title":"Nutr. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"C684","DOI":"10.1152\/ajpcell.00345.2024","article-title":"Decreased skeletal muscle intramyocellular lipid droplet-mitochondrial contact contributes to myosteatosis in cancer cachexia","volume":"327","author":"Cardaci","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.semcdb.2015.09.009","article-title":"Impaired regeneration: A role for the muscle microenvironment in cancer cachexia","volume":"54","author":"Talbert","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-981-13-1435-3_12","article-title":"NF-kB and Inflammatory Cytokine Signalling: Role in Skeletal Muscle Atrophy","volume":"1088","author":"Thoma","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41430-022-01201-7","article-title":"Prognostic value of myosteatosis and systemic inflammation in patients with resectable gastric cancer: A retrospective study","volume":"77","author":"Lascala","year":"2023","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Correa-De-Araujo, R., Rossi, A.P., Zamboni, M., Addison, O., Miljkovic, I., and Goodpaster, B. (2022). Editorial: Muscle Quality in Skeletal Muscle Function Deficit: Recent Advances and Potential Clinical and Therapeutic Implications. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.847883"},{"key":"ref_27","first-page":"260","article-title":"Epidemiology of myosteatosis","volume":"13","author":"Miljkovic","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e16042","DOI":"10.14814\/phy2.16042","article-title":"The effects of myosteatosis on skeletal muscle function in older adults","volume":"12","author":"Dondero","year":"2024","journal-title":"Physiol. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Stelmach-Mardas, M., Warcho\u0142, W., Garczyk, A., Warcho\u0142, E., Korczak, J., Litwiniuk, M., Brajer-Luftmann, B., and Mardas, M. (2024). Influence of Androgen Deprivation Therapy on the Development of Sarcopenia in Patients with Prostate Cancer: A Systematic Review. Nutrients, 16.","DOI":"10.20944\/preprints202401.1559.v1"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00432-025-06190-1","article-title":"Different cutoff values of the skeletal muscle mass and myosteatosis result in different clinical impact on overall survival in oncology. A subanalysis of a clinical trial","volume":"151","author":"Surov","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lortie, J., Rush, B., Osterbauer, K., Colgan, T.J., Tamada, D., Garlapati, S., Campbell, T.C., Traynor, A., Leal, T., and Patel, V. (2022). Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound. Front. Rehabil. Sci., 3, Erratum in Front. Rehabil. Sci. 2022, 3, 982949. https:\/\/doi.org\/10.3389\/fresc.2022.982949.","DOI":"10.3389\/fresc.2022.896114"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jcsm.13175","article-title":"Low L3 skeletal muscle index associated with the clinicopathological characteristics and prognosis of ovarian cancer: A meta-analysis","volume":"14","author":"Jin","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41430-021-00915-4","article-title":"Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT)","volume":"76","author":"Chan","year":"2022","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/gerona\/glz034","article-title":"Approaches to Assessment of Muscle Mass and Myosteatosis on Computed Tomography: A Systematic Review","volume":"74","author":"Amini","year":"2019","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e240282","DOI":"10.1148\/radiol.240282","article-title":"Preoperative Chest CT Myosteatosis Indicates Worse Postoperative Survival in Stage 0-IIB Non-Small Cell Lung Cancer","volume":"314","author":"Mantz","year":"2025","journal-title":"Radiology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.21037\/qims.2020.02.09","article-title":"Association of adipose tissue and skeletal muscle metrics with overall survival and postoperative complications in soft tissue sarcoma patients: An opportunistic study using computed tomography","volume":"10","author":"Boutin","year":"2020","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"112492","DOI":"10.1016\/j.nut.2024.112492","article-title":"Effect of contrast phase on quantitative analysis of skeletal muscle and adipose tissue by computed tomography","volume":"126","author":"Vedder","year":"2024","journal-title":"Nutrition"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3348\/kjr.2025.1140","article-title":"Effects of Computed Tomography Technical Parameters on Body-Composition Analysis","volume":"26","author":"Yoo","year":"2025","journal-title":"Korean J. Radiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101398","DOI":"10.1016\/j.arr.2021.101398","article-title":"Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: A new paradigm beyond sarcopenia","volume":"70","author":"Ahn","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e222008","DOI":"10.1148\/radiol.222008","article-title":"AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults","volume":"307","author":"Nachit","year":"2023","journal-title":"Radiology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.26502\/jcsct.5079271","article-title":"Myosteatosis in Oesophagogastric Cancer: A Systematic Review","volume":"9","author":"Deswysen","year":"2025","journal-title":"J. Cancer Sci. Clin. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Sales-Balaguer, N., Sorribes-Carreras, P., and Morillo Macias, V. (2024). Diagnosis of Sarcopenia and Myosteatosis by Computed Tomography in Patients with Esophagogastric and Pancreatic Cancer. Cancers, 16.","DOI":"10.3390\/cancers16152738"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Stretch, C., Aubin, J.M., Mickiewicz, B., Leugner, D., Al-Manasra, T., Tobola, E., Salazar, S., Sutherland, F.R., Ball, C.G., and Dixon, E. (2018). Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196235"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Chang, Y.Y., and Cheng, B. (2024). Prognostic impact of myosteatosis in patients with colorectal cancer undergoing curative surgery: An updated systematic review and meta-analysis. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1388001"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/jamasurg.2020.2497","article-title":"Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery","volume":"155","author":"Xiao","year":"2020","journal-title":"JAMA Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1245\/s10434-018-6652-x","article-title":"Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach","volume":"25","author":"Martin","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.clnu.2015.08.005","article-title":"The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma","volume":"35","author":"Rollins","year":"2016","journal-title":"Clin Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s11605-012-1923-5","article-title":"Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg","volume":"16","author":"Peng","year":"2012","journal-title":"J. Gastrointest. Surg."},{"key":"ref_49","first-page":"512","article-title":"Sarcopenia and myosteatosis are associated with poor prognosis in hepatocellular carcinoma","volume":"33","author":"Chen","year":"2023","journal-title":"Hepatol. Res."},{"key":"ref_50","first-page":"1102","article-title":"Impact of skeletal muscle quality on outcomes after liver transplantation for hepatocellular carcinoma","volume":"22","author":"Hamaguchi","year":"2016","journal-title":"Liver Transpl."},{"key":"ref_51","first-page":"2622","article-title":"Body composition in patients with non-small cell lung cancer: Impact on survival and chemotherapy toxicity","volume":"28","author":"Baracos","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_52","first-page":"223","article-title":"Skeletal muscle attenuation predicts outcomes in patients with advanced lung cancer","volume":"37","author":"Daly","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","article-title":"Association of muscle and adiposity measured by CT with survival in breast cancer","volume":"4","author":"Caan","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_54","first-page":"357","article-title":"Low muscle attenuation is associated with poor survival in metastatic breast cancer","volume":"163","author":"Rier","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/sms.12543","article-title":"Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapyImpact of skeletal muscle depletion and density on outcomes in prostate cancer patients receiving androgen deprivation therapy","volume":"26","author":"Nilsen","year":"2016","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"ref_56","first-page":"3973","article-title":"Sarcopenia and body composition in prostate cancer outcomes","volume":"123","author":"Brown","year":"2017","journal-title":"Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.oraloncology.2016.09.006","article-title":"Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients","volume":"62","author":"Swartz","year":"2016","journal-title":"Oral Oncol."},{"key":"ref_58","first-page":"2605","article-title":"Skeletal muscle attenuation and survival in head and neck cancer patients undergoing chemoradiotherapy","volume":"276","author":"Ufuk","year":"2019","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"djw145","DOI":"10.1093\/jnci\/djw145","article-title":"Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans","volume":"108","author":"Xiao","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/6\/974\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:42:53Z","timestamp":1773819773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/6\/974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cancers18060974"],"URL":"https:\/\/doi.org\/10.3390\/cancers18060974","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]}}}